Sanofi Pasteur gets FDA approval for Dengvaxia vaccine to prevent dengue disease

This article was originally published here

Dengvaxia is said to be the first FDA-approved vaccine to prevent dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people aged between

The post Sanofi Pasteur gets FDA approval for Dengvaxia vaccine to prevent dengue disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply